Biometric rules delay evacuation of Gaza children to UK
The children will receive NHS care and travel with one parent or caregiver under the scheme, which was announced by the UK government earlier this month.
Participants in the arrangement told The National the Gazan children in greatest need are first selected by doctors and then given permission to travel by the Cogat bureaucracy in Israel's Ministry of Defence, which co-ordinates their travel with the World Health Organisation (WHO).
The UK can evacuate children who are already on the WHO's list, the source explained. But there are concerns that the most urgent cases – such as severe burns – will be not make it to the UK's selection, as the Home Office requires the children to travel to Jordan or Egypt to have their biometric details processed for their visa.
Children approved for medical evacuation by the Israeli authorities exit Gaza through the border crossings to Israel, where they are then evacuated to the country where they will be treated. But the UK's biometric requirements mean they will also need to make the stopover in Amman or Cairo. The Home Office and Department of Health and Social Care have been contacted for comment.
This process has excluded Palestinian children from treatment in the UK in the past, according to Omar Din, a UK medical professional who has been co-ordinating medical evacuations for Palestinian children to Europe.
Earlier this year the UK responded to calls to evacuate Hatem, a two-year old orphan with 35 per cent burns, and Karam, a baby who suffered from an easily treatable birth defect. But it then acted too slowly, and Italy took the children instead, alongside 15 others, in an emergency evacuation on June 11.
Italy has waived its biometric requirement and brought over 180 children and adults from Gaza in 14 evacuations. MPs called on the UK government to bring the sick children 'without delay' this week, as the humanitarian crisis escalates and famine has been declared.
Among their demands was to 'waive the biometric requirements for evacuees under this scheme', in a letter signed by 96 cross-party MPs. 'The requirement for biometrics as a prerequisite to issue visas remains a major barrier, given that the only authorised biometrics centre in Gaza closed in October 2023,' the group warned.
'We urge you to waive biometric requirements for evacuees under this scheme and permit applications to be completed after departure from Gaza.' They also said it was 'vital' for the children's carers or parents to accompany them to the UK and be with them during treatment.
'There is clear medical evidence to suggest their presence can positively impact the recovery of sick or injured children,' they said. The UK government has said it will allow one caregiver to travel with the child.
The UK's decision to treat Palestinian children on the NHS came after over 18 months of campaigning from MPs and British doctors. So far, 7,528 patients have been evacuated from Gaza for medical treatment, according to the WHO. But only three are currently being treated in the UK.
Since July 2024, the treatment has been mainly for trauma (712 cases) and cancer (660), followed by eye disorders (250), birth defects (240) and heart disease (208).
Project Pure Hope had raised the funds to treat up to 50 children privately but it took them 19 months to get their first visa. It now has three Palestinian children in the UK for private treatment and hopes to continue running its scheme in parallel to the UK government.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
11 minutes ago
- Zawya
Jordan takes prime position as MENA's medical tourism destination with strong growth in international visitors
Specialized treatments and world-class healthcare facilities drive sector growth Natural therapeutic destinations complement advanced medical services and world-class clinicians and professionals Amman, Jordan: Jordan is taking the prime position as the Middle East and North Africa region's leading medical tourism destination, with record growth in visitor arrivals for specialized medical care and natural therapy during the first seven months of 2025. This builds on the over 224,000 medical tourists who visited Jordan last year, recording a consistent growth in numbers – from 191,532 in 2022 and 202,592 in 2023. The growth is supported by two key drivers: One, the increase in specialized healthcare offerings backed by an expert pool of clinicians and healthcare professionals; and two, the natural offerings of the country that serve to soothe the body and mind. Today, the global medical tourism market is witnessing significant growth, with valuations ranging from USD 31.23 billion to USD 41.79 billion in 2024, and projections indicating expansion to over USD 160 billion by 2032. The MENA region, particularly the GCC countries, has historically been a significant source of outbound medical tourists. According to estimates, Kuwait alone sends approximately 650 patients monthly for overseas treatment, with annual costs reaching about 1 billion USD, while Saudi Arabia's Health Ministry reported 2,400 patients treated abroad at a cost of US$ 800 million. Against this backdrop, Jordan has emerged as a premier medical tourism destination in the MENA region, generating more than 1 billion USD in revenue annually and accounting for approximately 4% of the nation's GDP. Having welcomed over 51,448 medical tourists in the first quarter of 2025, which increased to 92,776 by the end of May, a growth of 16.5% over the same period last year, Jordan's medical tourism sector is set to achieve a new milestone this year. Jordan's appeal as a medical tourism destination is particularly strong among Gulf Cooperation Council (GCC) nations and neighboring countries. A significant portion of the annual medical tourists are from countries such as Iraq, Saudi Arabia, Palestine, Syria, Yemen, Libya, and other Gulf nations. "Our medical tourism sector has a legacy that dates back to the 1970s, when Jordan emerged as one of the top destinations for medical care in the region. The sector is continuing to demonstrate exceptional growth as a preferred therapeutic destination both regionally and globally," said Dr. Abdelrazzak Arabiyat, Managing Director of the Jordan Tourism Board. The country's notable milestones in the healthcare sector include conducting the first open-heart surgery in 1970, followed by the first kidney transplant in 1972. The King Hussein Cancer Center (KHCC) has reported significant medical achievements, including 250 bone marrow transplants in 2022 alone, with success rates exceeding 85%, on par with international rates. "The growth in medical tourism is primarily driven by the world-class healthcare services that our hospitals offer, the popularity of the natural therapeutic sites and the renowned hospitality of our country. What sets the country's medical tourism sector are the cost-effective yet high quality care assured within the country and the diverse natural attractions that add to the well-being of the patients and those who accompany them,' added Dr. Arabiyat. According to estimates, a primary draw for international medical visitors is the substantial cost savings offered. Treatment prices in Jordan are reported to be about 25% to 40% less than those in the United States and Europe, and even 5% to 10% lower than in other prominent medical tourism hubs such as India, Singapore, and Thailand. A robust healthcare infrastructure Jordan's healthcare ecosystem is world-class with over 120 hospitals and medical centers, including 71 private and 47 public health institutions. Many of these facilities have prestigious international accreditations from organizations such as the Joint Commission International (JCI) and the Health Care Accreditation Council (HCAC). This provides peace of mind to medical tourists that they are assured of the highest standards of patient care and safety. Jordan Hospital, Specialty Hospital, Abdali Hospital, Al-Kindi Hospital, Ibn Al-Haytham Hospital, Arab Medical Center and King Hussein Cancer Center are leading names in the private sector, while Royal Medical Services (Medical City) and Al-Bashir Hospital are among the top choices in the public sector for medical tourists. Another strength of the country is its medical workforce of more than 30,000 professionals, many of them Western-educated and board-certified, who deliver specialized treatments ranging from advanced cardiac procedures and cancer care to orthopedic surgeries and fertility treatments. The absence of considerable waiting lists for procedures and the widespread availability of English-speaking medical staff and surgeons contribute substantially to patient convenience and confidence. Complementing the country's advanced medical facilities are unique natural therapeutic sites that enhance patient recovery and wellness. The Dead Sea, 400 meters below sea level, provides exceptional therapeutic benefits through its mineral-rich waters containing 33% salt content. Ma'in Hot Springs, with mineral-rich waters reaching temperatures of 60°C, is renowned for its therapeutic benefits for skin conditions, joint pain, and circulatory problems. Contribution to the national economy Medical tourism contributes significantly to the country's national income, providing thousands of job opportunities and supports many related sectors. It is estimated that a medical tourist spends 3 to 5 times more than a regular tourist due to extended stays. The country's hospitality infrastructure is well positioned to support the sector with a diverse range of accommodation facilities for patients and their companions. Other conveniences include ease of transportation with pickup and drop-off services, and translation services provided in multiple languages with support from specialized offices and companies. "The diversity of medical specialties available in Jordan, combined with our natural therapeutic destinations and skilled healthcare professionals, has created a strong and sustainable medical tourism ecosystem," added Dr. Arabiyat. "Over the years, we have been focused on promoting our strengths in medical tourism through targeted digital ad campaigns, promotional videos and FAM trips for media and medical delegations, all contributing to the popularity of the country for world-class medical care." For more information about medical tourism in Jordan, visit About Jordan Tourism Board The Jordan Tourism Board (JTB) was launched in March 1998 as an independent, public-private sector partnership committed to utilize marketing strategies to brand, position and promote the Jordan tourism product as the destination of choice in the international markets. The adopted strategies are tuned to reflect the true image of the Jordan tourism product, being a cultural, natural, religious, adventurous, leisure and MICE destination. As part of its marketing strategies, the JTB plans and executes an integrated program of international promotional activities. This program includes the active participation in trade fairs, trade workshops, trade and consumer road shows, familiarization trips, press trips, brochure & multimedia production, and media relations. To carry out its goals, the Jordan Tourism Board utilizes the services of eleven offices in Europe and N. America. For more details, visit:
Zawya
11 minutes ago
- Zawya
Cleveland Clinic Abu Dhabi provides advanced first-of-its-kind stroke treatment in MENA region
As designated Center of Excellence for stroke, the hospital continues to expand access to safer, minimally invasive treatments for complex neurovascular conditions. The hospital's multidisciplinary team of neurological experts delivers highly specialized care using advanced imaging and catheter-based precision to reduce surgical risks and improve long-term outcomes. Abu Dhabi: Cleveland Clinic Abu Dhabi has set a new standard in the treatment of brain aneurysms in the Middle East and North Africa (MENA) region, adopting the first Artisse Intrasaccular Flow Modulator, a novel medical implant for wide-necked intracranial aneurysms. Designated by the Department of Health – Abu Dhabi as a Centre of Excellence (CoE), this milestone underscores the hospital's position for stroke as it continues to advance medical technology and deliver world-class care for patients. Cerebral aneurysms, or strokes, occur when a weakened area in a blood vessel wall in the brain causes a bulge or balloon-like expansion, posing significant risks if untreated, including subarachnoid hemorrhage, a type of stroke caused by bleeding in the brain. Traditionally, treating aneurysms requires invasive open surgery. However, recent advancements in minimally invasive procedures have transformed how these conditions are managed, offering safer and more effective options for patients. The procedure begins with a minimally invasive technique where a catheter is inserted through the patient's blood vessels, typically from the groin or arm, to reach the aneurysm in the brain. Using advanced 3D imaging and angiograms, physicians can visualize and assess the aneurysm with precision. Once positioned, the unique mesh device is deployed into the aneurysm and fills it, preventing blood from entering, reducing the risk of rupture and associated complications like subarachnoid hemorrhage. This innovative technique is particularly useful for aneurysms with wide necks, which are typically challenging to treat using traditional methods. The device stays in place permanently, eliminating the need for further invasive surgery while providing long-term protection against rupture. The procedure itself can take between two to eight hours, depending on the complexity of the aneurysm. Following the treatment, patients undergo follow-up imaging at regular intervals, typically at three and six months, to ensure the device is effectively treating the aneurysm. For the first patient treated with this device at Cleveland Clinic Abu Dhabi, follow-up imaging at three months showed successful occlusion of the aneurysm, demonstrating the promising potential of this innovative treatment. This innovative technology marks a significant leap forward in cerebral aneurysm treatment. Unlike traditional methods that rely on multiple coils or filaments to occlude the aneurysm, this unique device uses a single, intricately designed mesh structure that effectively seals off the aneurysm, preventing blood flow and drastically reducing the risk of rupture. The adoption of the technology at Cleveland Clinic Abu Dhabi enhances current treatment options and paves the way for future advancements in neurological care. Dr. Fayeza Al Yafie, Executive Director of the Healthcare Quality Sector at the Department of Health – Abu Dhabi (DoH), said: 'Centers of Excellence in Abu Dhabi continue to affirm their commitment to enhancing the healthcare system by providing specialized care and utilizing the emirate's advanced infrastructure. Abu Dhabi's dynamic regulatory environment encourages research and innovation in the continuous development and attraction of talent, as well as cutting-edge technologies and treatments that contribute to the health and safety of community members. We congratulate Cleveland Clinic Abu Dhabi on this milestone and look forward to working together to position the healthcare system in the emirate among the best and most intelligent globally.' Dr. Khalil Zahra, Staff Physician, Neurosurgery, Neurological Institute at Cleveland Clinic Abu Dhabi, said: "The introduction of this novel stroke technology in our region enhances our ability to treat complex aneurysms and demonstrates our ongoing commitment to bringing the latest medical advancements to our patients. This technology, combined with our multidisciplinary approach to patient care, ensures that we continue to provide world-class treatment options for even the most challenging neurological conditions. The successful implementation of the device in its first procedure marks a new era in the treatment of cerebral aneurysms, offering our patients a safer, more efficient, and less invasive treatment option." Dr Zahra added: 'This technology serves as a springboard for further innovation in our field. Combining our experience with the new technology, we will inform future research initiatives, potentially leading to even more refined treatment methods for complex cerebrovascular conditions. Moreover, as we gather long-term data on patient outcomes, we expect to contribute valuable insights to the global neurosurgical community, further solidifying Cleveland Clinic Abu Dhabi's position as a leader in neurological care and research in the MENA region.' The successful implementation of the device at Cleveland Clinic Abu Dhabi is a testament to the Neurological Institute's comprehensive, multidisciplinary approach to care. By bringing together experts from various specialties, including neurosurgery, interventional neuroradiology, and neurology, this collaborative model ensures that each patient receives personalized treatment plans that leverage the full potential of cutting-edge technologies. As designated Centre of Excellence for stroke, Cleveland Clinic Abu Dhabi was chosen as the launch site for this breakthrough device. The hospital remains at the forefront of neurological care in the MENA region, continuously seeking innovative solutions to improve patient outcomes and quality of life. The addition of the Artisse Intrasaccular Flow Modulator device to the hospital's treatment arsenal is yet another testament to its leadership in the field. About Cleveland Clinic Abu Dhabi Cleveland Clinic Abu Dhabi is a multispecialty hospital located on Al Maryah Island in Abu Dhabi, UAE. As an extension of Cleveland Clinic in the U.S., it is uniquely designed to address the complex and critical care needs of the UAE and the broader region. The hospital is organized into specialized Institutes, including Heart, Vascular & Thoracic; Neurological; Cancer; Digestive Disease; Medical Subspecialties; Integrated Surgical Subspecialties; Integrated Hospital Care; and Diagnostic. Celebrating its 10th anniversary in 2025, Cleveland Clinic Abu Dhabi is a 405-bed hospital, including 321 acute care beds, 84 critical care beds, four royal suites, and 26 operating rooms. Its state-of-the-art facilities provide patients in the region with direct access to world-class healthcare providers and Cleveland Clinic's renowned model of care. The hospital is also home to the Fatima bint Mubarak Center, a dedicated cancer center offering comprehensive diagnostics and advanced treatment across 24 clinical departments, covering a range of cancer subspecialties and programs. Committed to medical innovation, Cleveland Clinic Abu Dhabi integrates robotics across specialties, pioneers' endovascular therapy and hybrid procedures, and offers comprehensive programs in heart failure, heart transplantation, and limb salvage. Licensed by the Department of Health – Abu Dhabi as a designated research and teaching facility, Cleveland Clinic Abu Dhabi drives medical innovation through clinical trials and advanced research to enhance patient care. It is the first hospital in the UAE accredited by both the Accreditation Council for Graduate Medical Education International (ACGMEI) and the Accreditation Council for Continuing Medical Education (ACCME), offering residency and fellowship programs, undergraduate health professional training, and Continuing Medical Education (CME). M42 is a global, tech-enabled healthcare company based in Abu Dhabi, operating at the forefront of medical advancement. Media contact Farah Chaaban –
Middle East Eye
2 hours ago
- Middle East Eye
Gaza genocide: Airdropped aid package kills Palestinian man
An airdropped aid package has killed an elderly Palestinian man in the so-called humanitarian zone in southern Gaza. Saber al-Zamili, 75, was inside a tent when the package fell directly on him on Sunday, according to his family. He was preparing to head to the mosque for his daily prayers, his son Wael al-Zamili told Middle East Eye. His daughter Sarah al-Zamili said his body was retrieved from beneath the package with severe injuries. "His entire body was broken," she said through tears, adding that they rushed him to the Kuwaiti Hospital in Rafah. New MEE newsletter: Jerusalem Dispatch Sign up to get the latest insights and analysis on Israel-Palestine, alongside Turkey Unpacked and other MEE newsletters He was later transferred to Nasser Hospital in Khan Younis, where he was pronounced dead. "This is not a safe method of distributing aid - not the airdrops, not the American aid deliveries, nor the trucks," she told MEE, referring to the Gaza Humanitarian Foundation (GHF), which employs a militarised distribution mechanism. "This is cruelty against the Palestinian people. What they are doing to us is unjust… This is not a way to feed the Palestinian people; it's a method of humiliation and oppression." Palestinians mourn 75-year-old Saber al-Zamili, who was killed during a relief airdrop operation in al-Mawasi, southern Gaza (MEE/Ahmed Aziz) She stressed that proper aid distribution should be carried out through coordinated and secure efforts by recognised humanitarian organisations. "None of what is being done is helping the Palestinian people. It is only deepening our suffering," she said. 'Dying from starvation is more honourable than dying like this.' Endangering civilians International organisations have repeatedly warned that airdropped aid can endanger civilians. Despite this, the Israeli military announced in late July it would resume aerial deliveries to Gaza, in coordination with several regional and European countries. Rights groups and humanitarian experts have criticised the method. They say it puts lives at risk, offers insufficient aid and lacks fair distribution. Airdrops have also triggered deadly stampedes, as desperate crowds rush towards falling crates. Rania al-Abed, a witness to the chaos, told MEE the current system, including GHF-run sites, is unorganised and chaotic. War on Gaza: Why air-dropping aid on Gaza is doing more harm than good Read More » She described scenes of overcrowding and panic at every aid drop. 'More than once, I've taken martyrs to the hospital,' she said. 'I'm not going for food or water, just to remove the dead… What kind of life is this?' Abed said she no longer seeks aid for herself. Instead, she focuses on helping others, and carrying the dead away from aid sites. One of them was her own father. She found him by chance, killed at a distribution point. A bullet from Israeli shelling had struck his chest. 'How long must we live like this? How long must we suffer?' she asked. 'I swear to God, we are exhausted. I've lost my father, my mother, I've lost everything. I have nothing left. I'm only doing this for God.' She said aid sites have become firing zones. Israeli forces shoot into crowds, even when there is clear distance between them and civilians. 'It's injustice,' she said. Israeli forces have killed nearly 2,000 Palestinians queueing up for food at GHF distribution sites since May, according to the health ministry. At least 23 have died from airdropped aid and 124 more wounded. Overall, Israeli forces have killed more than 62,000 and wounded over 156,000 since the genocide in Gaza began in October 2023.
